Selected research
Industry Research
Bone and Joint Health Products Industry Research Report 2026
Market perspective
The global Bone and Joint Health Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bone and Joint Health Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bone and Joint Health Products is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bone and Joint Health Products is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bone and Joint Health Products include Pfizer, Swisse, NOW Foods, NutraScience Labs, Nature's Way, Abbott Laboratories, Schiff Nutrition International, Solgar and GNC Holdings, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bone and Joint Health Products market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bone and Joint Health Products Market by Company
Pfizer
Swisse
NOW Foods
NutraScience Labs
Nature's Way
Abbott Laboratories
Schiff Nutrition International
Solgar
GNC Holdings
New Chapter
Bayer
Nutramax Laboratories
Herbalife Nutrition
Life Extension
Jarrow Formulas
Twinlab
By-Health
Harbin Pharmaceutical Group
Bone and Joint Health Products Segment by Type
Vitamins
Minerals
Collagen
Omega-3
Glucosamine
Other
Bone and Joint Health Products Segment by Application
Online Sales
Offline Sales
Bone and Joint Health Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bone and Joint Health Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bone and Joint Health Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bone and Joint Health Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bone and Joint Health Products manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bone and Joint Health Products by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bone and Joint Health Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vitamins
- Minerals
- Collagen
- Omega-3
- Glucosamine
- Other
Applications
- Online Sales
- Offline Sales
Companies covered
- Pfizer
- Swisse
- NOW Foods
- NutraScience Labs
- Nature's Way
- Abbott Laboratories
- Schiff Nutrition International
- Solgar
- GNC Holdings
- New Chapter
- Bayer
- Nutramax Laboratories
- Herbalife Nutrition
- Life Extension
- Jarrow Formulas
- Twinlab
- By-Health
- Harbin Pharmaceutical Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bone and Joint Health Products Market Size (2021-2032)
- 2.2.2 Global Bone and Joint Health Products Sales (2021-2032)
- 2.2.3 Global Bone and Joint Health Products Market Average Price (2021-2032)
- 2.3 Bone and Joint Health Products by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Vitamins
- 2.3.3 Minerals
- 2.3.4 Collagen
- 2.3.5 Omega-3
- 2.3.6 Glucosamine
- 2.3.7 Other
- 2.4 Bone and Joint Health Products by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bone and Joint Health Products Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bone and Joint Health Products Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Bone and Joint Health Products Revenue of Manufacturers (2021-2026)
- 3.4 Global Bone and Joint Health Products Average Price by Manufacturers (2021-2026)
- 3.5 Global Bone and Joint Health Products Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bone and Joint Health Products, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bone and Joint Health Products, Product Type & Application
- 3.8 Global Manufacturers of Bone and Joint Health Products, Established Date
- 3.9 Global Bone and Joint Health Products Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer
- 4.1.1 Pfizer Company Information
- 4.1.2 Pfizer Business Overview
- 4.1.3 Pfizer Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer Bone and Joint Health Products Product Portfolio
- 4.1.5 Pfizer Recent Developments
- 4.2 Swisse
- 4.2.1 Swisse Company Information
- 4.2.2 Swisse Business Overview
- 4.2.3 Swisse Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Swisse Bone and Joint Health Products Product Portfolio
- 4.2.5 Swisse Recent Developments
- 4.3 NOW Foods
- 4.3.1 NOW Foods Company Information
- 4.3.2 NOW Foods Business Overview
- 4.3.3 NOW Foods Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 NOW Foods Bone and Joint Health Products Product Portfolio
- 4.3.5 NOW Foods Recent Developments
- 4.4 NutraScience Labs
- 4.4.1 NutraScience Labs Company Information
- 4.4.2 NutraScience Labs Business Overview
- 4.4.3 NutraScience Labs Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 NutraScience Labs Bone and Joint Health Products Product Portfolio
- 4.4.5 NutraScience Labs Recent Developments
- 4.5 Nature's Way
- 4.5.1 Nature's Way Company Information
- 4.5.2 Nature's Way Business Overview
- 4.5.3 Nature's Way Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Nature's Way Bone and Joint Health Products Product Portfolio
- 4.5.5 Nature's Way Recent Developments
- 4.6 Abbott Laboratories
- 4.6.1 Abbott Laboratories Company Information
- 4.6.2 Abbott Laboratories Business Overview
- 4.6.3 Abbott Laboratories Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Abbott Laboratories Bone and Joint Health Products Product Portfolio
- 4.6.5 Abbott Laboratories Recent Developments
- 4.7 Schiff Nutrition International
- 4.7.1 Schiff Nutrition International Company Information
- 4.7.2 Schiff Nutrition International Business Overview
- 4.7.3 Schiff Nutrition International Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Schiff Nutrition International Bone and Joint Health Products Product Portfolio
- 4.7.5 Schiff Nutrition International Recent Developments
- 4.8 Solgar
- 4.8.1 Solgar Company Information
- 4.8.2 Solgar Business Overview
- 4.8.3 Solgar Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Solgar Bone and Joint Health Products Product Portfolio
- 4.8.5 Solgar Recent Developments
- 4.9 GNC Holdings
- 4.9.1 GNC Holdings Company Information
- 4.9.2 GNC Holdings Business Overview
- 4.9.3 GNC Holdings Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 GNC Holdings Bone and Joint Health Products Product Portfolio
- 4.9.5 GNC Holdings Recent Developments
- 4.10 New Chapter
- 4.10.1 New Chapter Company Information
- 4.10.2 New Chapter Business Overview
- 4.10.3 New Chapter Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 New Chapter Bone and Joint Health Products Product Portfolio
- 4.10.5 New Chapter Recent Developments
- 4.11 Bayer
- 4.11.1 Bayer Company Information
- 4.11.2 Bayer Business Overview
- 4.11.3 Bayer Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bayer Bone and Joint Health Products Product Portfolio
- 4.11.5 Bayer Recent Developments
- 4.12 Nutramax Laboratories
- 4.12.1 Nutramax Laboratories Company Information
- 4.12.2 Nutramax Laboratories Business Overview
- 4.12.3 Nutramax Laboratories Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Nutramax Laboratories Bone and Joint Health Products Product Portfolio
- 4.12.5 Nutramax Laboratories Recent Developments
- 4.13 Herbalife Nutrition
- 4.13.1 Herbalife Nutrition Company Information
- 4.13.2 Herbalife Nutrition Business Overview
- 4.13.3 Herbalife Nutrition Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Herbalife Nutrition Bone and Joint Health Products Product Portfolio
- 4.13.5 Herbalife Nutrition Recent Developments
- 4.14 Life Extension
- 4.14.1 Life Extension Company Information
- 4.14.2 Life Extension Business Overview
- 4.14.3 Life Extension Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Life Extension Bone and Joint Health Products Product Portfolio
- 4.14.5 Life Extension Recent Developments
- 4.15 Jarrow Formulas
- 4.15.1 Jarrow Formulas Company Information
- 4.15.2 Jarrow Formulas Business Overview
- 4.15.3 Jarrow Formulas Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Jarrow Formulas Bone and Joint Health Products Product Portfolio
- 4.15.5 Jarrow Formulas Recent Developments
- 4.16 Twinlab
- 4.16.1 Twinlab Company Information
- 4.16.2 Twinlab Business Overview
- 4.16.3 Twinlab Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Twinlab Bone and Joint Health Products Product Portfolio
- 4.16.5 Twinlab Recent Developments
- 4.17 By-Health
- 4.17.1 By-Health Company Information
- 4.17.2 By-Health Business Overview
- 4.17.3 By-Health Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 By-Health Bone and Joint Health Products Product Portfolio
- 4.17.5 By-Health Recent Developments
- 4.18 Harbin Pharmaceutical Group
- 4.18.1 Harbin Pharmaceutical Group Company Information
- 4.18.2 Harbin Pharmaceutical Group Business Overview
- 4.18.3 Harbin Pharmaceutical Group Bone and Joint Health Products Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Harbin Pharmaceutical Group Bone and Joint Health Products Product Portfolio
- 4.18.5 Harbin Pharmaceutical Group Recent Developments
5 Global Bone and Joint Health Products Market Scenario by Region
- 5.1 Global Bone and Joint Health Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bone and Joint Health Products Sales by Region: 2021-2032
- 5.2.1 Global Bone and Joint Health Products Sales by Region: 2021-2026
- 5.2.2 Global Bone and Joint Health Products Sales by Region: 2027-2032
- 5.3 Global Bone and Joint Health Products Revenue by Region: 2021-2032
- 5.3.1 Global Bone and Joint Health Products Revenue by Region: 2021-2026
- 5.3.2 Global Bone and Joint Health Products Revenue by Region: 2027-2032
- 5.4 North America Bone and Joint Health Products Market Facts & Figures by Country
- 5.4.1 North America Bone and Joint Health Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bone and Joint Health Products Sales by Country (2021-2032)
- 5.4.3 North America Bone and Joint Health Products Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Bone and Joint Health Products Market Facts & Figures by Country
- 5.5.1 Europe Bone and Joint Health Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bone and Joint Health Products Sales by Country (2021-2032)
- 5.5.3 Europe Bone and Joint Health Products Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Bone and Joint Health Products Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bone and Joint Health Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bone and Joint Health Products Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bone and Joint Health Products Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bone and Joint Health Products Market Facts & Figures by Country
- 5.7.1 South America Bone and Joint Health Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bone and Joint Health Products Sales by Country (2021-2032)
- 5.7.3 South America Bone and Joint Health Products Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Bone and Joint Health Products Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bone and Joint Health Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bone and Joint Health Products Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bone and Joint Health Products Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Bone and Joint Health Products Sales by Type (2021-2032)
- 6.1.1 Global Bone and Joint Health Products Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Bone and Joint Health Products Sales Market Share by Type (2021-2032)
- 6.2 Global Bone and Joint Health Products Revenue by Type (2021-2032)
- 6.2.1 Global Bone and Joint Health Products Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bone and Joint Health Products Revenue Market Share by Type (2021-2032)
- 6.3 Global Bone and Joint Health Products Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bone and Joint Health Products Sales by Application (2021-2032)
- 7.1.1 Global Bone and Joint Health Products Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Bone and Joint Health Products Sales Market Share by Application (2021-2032)
- 7.2 Global Bone and Joint Health Products Revenue by Application (2021-2032)
- 7.2.1 Global Bone and Joint Health Products Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bone and Joint Health Products Revenue Market Share by Application (2021-2032)
- 7.3 Global Bone and Joint Health Products Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bone and Joint Health Products Value Chain Analysis
- 8.1.1 Bone and Joint Health Products Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bone and Joint Health Products Production Mode & Process
- 8.2 Bone and Joint Health Products Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bone and Joint Health Products Distributors
- 8.2.3 Bone and Joint Health Products Customers
9 Global Bone and Joint Health Products Analyzing Market Dynamics
- 9.1 Bone and Joint Health Products Industry Trends
- 9.2 Bone and Joint Health Products Industry Drivers
- 9.3 Bone and Joint Health Products Industry Opportunities and Challenges
- 9.4 Bone and Joint Health Products Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst